BlueCrest Capital Management’s Pediatrix Medical MD Stock Holding History

BlueCrest Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,363	Closed	-$227K	–	797
2019 Q1	$227K	Sell	8,363 -44,065	-84%	-$1.48M	0.01%	874
2018 Q4	$1.73M	Buy	52,428 +47,384	+939%	+$1.91M	0.09%	151
2018 Q3	$235K	Buy	+5,044	New	+$232K	0.01%	1186
2018 Q2	–	Sell	-5,384	Closed	-$300K	–	1691
2018 Q1	$300K	Sell	5,384 -29,863	-85%	-$1.64M	0.01%	1055
2017 Q4	$1.88M	Buy	35,247 +5,041	+17%	+$238K	0.05%	281
2017 Q3	$1.3M	Buy	+30,206	New	+$1.44M	0.05%	333
2016 Q2	–	Sell	-16,250	Closed	-$1.05M	–	975
2016 Q1	$1.05M	Buy	+16,250	New	+$1.08M	0.06%	365
2015 Q4	–	Sell	-25,096	Closed	-$1.93M	–	1098
2015 Q3	$1.93M	Buy	+25,096	New	+$2.03M	0.06%	287

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

BlueCrest Capital Management's MD Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Pediatrix Medical (MD) in Q2 2019, closing a stake of 8,363 shares — an estimated $227K sold.

BlueCrest Capital Management first reported a position in MD in Q3 2015 and held it in 8 quarters. The position peaked at $1.93M in Q3 2015. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

BlueCrest Capital Management reported no remaining Pediatrix Medical position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 8,363 Pediatrix Medical shares in Q2 2019, an estimated $227K.
BlueCrest Capital Management first reported a position in Pediatrix Medical in Q3 2015 and held it in 8 quarters.
BlueCrest Capital Management's Pediatrix Medical position peaked at $1.93M in Q3 2015.
247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.